BE788010A - Emballage pharmaceutique - Google Patents

Emballage pharmaceutique

Info

Publication number
BE788010A
BE788010A BE788010A BE788010A BE788010A BE 788010 A BE788010 A BE 788010A BE 788010 A BE788010 A BE 788010A BE 788010 A BE788010 A BE 788010A BE 788010 A BE788010 A BE 788010A
Authority
BE
Belgium
Prior art keywords
pharmaceutical packaging
packaging
pharmaceutical
Prior art date
Application number
BE788010A
Other languages
English (en)
Inventor
E J Segre
Original Assignee
Syntex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Corp filed Critical Syntex Corp
Publication of BE788010A publication Critical patent/BE788010A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
BE788010A 1971-08-25 1972-08-25 Emballage pharmaceutique BE788010A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17493471A 1971-08-25 1971-08-25

Publications (1)

Publication Number Publication Date
BE788010A true BE788010A (fr) 1972-12-18

Family

ID=22638126

Family Applications (1)

Application Number Title Priority Date Filing Date
BE788010A BE788010A (fr) 1971-08-25 1972-08-25 Emballage pharmaceutique

Country Status (6)

Country Link
US (1) US3733407A (fr)
BE (1) BE788010A (fr)
DE (1) DE2241740A1 (fr)
FR (1) FR2150850B1 (fr)
GB (1) GB1397441A (fr)
NL (1) NL170229C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117883212A (zh) * 2024-03-15 2024-04-16 中国中医科学院中药研究所 一种改良型经前期综合征动物模型的构建方法和动物模型及应用

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2310963A1 (de) * 1972-04-14 1974-09-05 Schering Ag Methode zur kontrazeption durch verabfolgung von stufenkombinationspraeparaten
US4066757A (en) * 1973-03-26 1978-01-03 Ortho Pharmaceutical Corporation Oral contraceptive regimen
DE2365103C3 (de) * 1973-12-21 1980-08-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen V erwendung von Hormonen zur Kontrazeption
US4315925A (en) * 1980-05-30 1982-02-16 University Of Kentucky Research Foundation Method of administering natural female sex hormones
US4425339A (en) * 1981-04-09 1984-01-10 Syntex (U.S.A.) Inc. Treatment of menopausal symptoms
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4961931A (en) * 1982-07-29 1990-10-09 Alza Corporation Method for the management of hyperplasia
AU582540B2 (en) * 1983-08-05 1989-04-06 Pre Jay Holdings Ltd. A method of hormonal treatment of perimenopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
US5188835A (en) * 1986-06-16 1993-02-23 Kabi Pharmacia Ab Intravaginal devices
US4900734A (en) * 1987-08-27 1990-02-13 Maxson Wayne S Novel pharmaceutical composition containing estradiol and progesterone for oral administration
DE4104385C1 (fr) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich
DE4313926A1 (de) * 1993-04-28 1994-11-03 Jenapharm Gmbh Pharmazeutisches Mehrphasenpräparat zur hormonalen Kontrazeption
DE4342091A1 (de) * 1993-12-09 1995-06-14 Asta Medica Ag Erzeugnisse zur Anwendung von initial hohen Dosen von Cetrorelix und Herstellung einer Kombinationspackung zur Verwendung bei Therapie von Krankheiten
DE4344405C2 (de) * 1993-12-24 1995-12-07 Marika Dr Med Ehrlich Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption
US5789443A (en) * 1997-04-25 1998-08-04 Gollobin; Charlotte Method for treating flushing associated with menopause
US6703367B1 (en) 1999-04-27 2004-03-09 Praecis Pharmaceuticals Inc. Methods for treating hot flashes and gynaecomastia
US6245812B1 (en) 1999-07-15 2001-06-12 Charlotte Gollobin Treatment of hot flashes (flushing) using leucine alone or in combination with other branched chain amino acids
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
CA2521471A1 (fr) * 2003-04-11 2004-10-28 Barr Laboratories, Inc. Procede d'administration d'oestrogenes et de progestatifs
US7623924B2 (en) * 2004-08-31 2009-11-24 Leptos Biomedical, Inc. Devices and methods for gynecologic hormone modulation in mammals
WO2006084082A1 (fr) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions d'oestrogenes non conjugues et procedes destines a leur utilisation
UY33103A (es) 2009-12-15 2011-07-29 Techsphere S A De C V Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117883212A (zh) * 2024-03-15 2024-04-16 中国中医科学院中药研究所 一种改良型经前期综合征动物模型的构建方法和动物模型及应用

Also Published As

Publication number Publication date
DE2241740A1 (de) 1973-03-01
FR2150850B1 (fr) 1977-08-05
FR2150850A1 (fr) 1973-04-13
NL170229C (nl) 1982-10-18
NL7211501A (fr) 1973-02-27
US3733407A (en) 1973-05-15
NL170229B (nl) 1982-05-17
GB1397441A (en) 1975-06-11

Similar Documents

Publication Publication Date Title
BE788010A (fr) Emballage pharmaceutique
IT968486B (it) Confezione di contenitori
BE761544A (fr) Emballage
BE759374A (fr) Emballage pour medicament
SE404164B (sv) Blisterforpackning
CH495897A (fr) Emballage de conditionnement pour ampoules pharmaceutiques
BE787129A (fr) Emballage multiple
AT329434B (de) Blisterpackung
CH537845A (de) Verpackung
BE791315A (fr) Emballage multiple
BE812150A (fr) Emballage
CH536236A (fr) Emballage
BE786653A (nl) Verpakking
IT942146B (it) Contenitore di medicamento
BE801738A (fr) Emballage
IT971976B (it) Contenitore d imballaggio
IT974263B (it) Contenitore d imballaggio richiu dibile
BE776769A (fr) Composition pharmaceutique
BE801990A (fr) Emballage transparent
BE764280A (fr) Materiau d'emballage
BE779235A (fr) Emballage
CH541476A (fr) Emballage pour pâtisserie
BE779769A (fr) Emballage aseptique
BR7200422D0 (pt) Embalagem para comprimidos drageas capsulas e similares
SE395431B (sv) Forpackningsmaterial